AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own NVR today, you really have to believe in its ability to convert a disciplined, high-return business model into steady long-term value, even when the near-term picture gets tougher. The latest quarter underlines that tension: net income and EPS are clearly down year-on-year, yet management still leaned into capital returns, completing a US$442.25 million buyback at a time when earnings are under pressure and the share price has already retreated over the past year. That mix probably amplifies shorter-term catalysts like any stabilization in orders or margins, while also sharpening the focus on execution risk if profits continue to soften. The pause on the newer May 2026 authorization hints that management may be more cautious near term, which could slightly rebalance the story from pure capital return toward protecting financial flexibility.
However, one key operational risk could matter more than the headline earnings drop investors just saw. Despite retreating, NVR's shares might still be trading 7% above their fair value. Discover the potential downside here.Explore 4 other fair value estimates on NVR - why the stock might be worth 41% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com